Comparision of Visual Outcomes and Patient Satisfaction Between Two Diffractive Trifocal Intraocular Lenses
1 other identifier
observational
30
1 country
1
Brief Summary
The purpose of the present study was to compare the clinical outcomes such as visual function, refraction errors and visual quality of patients undergoing cataract surgery with implantation of two different models of diffractive trifocal IOLs: RayOne Trifocal (Rayner IOL, Ltd.) and AcrySof IQ PanOptix (Alcon Laboratories, Inc.) IOL.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 30, 2020
CompletedStudy Start
First participant enrolled
November 30, 2020
CompletedFirst Posted
Study publicly available on registry
December 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2021
CompletedApril 2, 2021
March 1, 2021
4 months
November 30, 2020
March 31, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
The Quality of Vision score
Glare, halos, starbursts, hazy/blurred/double vision, distortion, focusing difficulties, fluctuation, and depth perception
3 months
Study Arms (2)
RayOne Trifocal intraocular lenses
Eyes of patients undergoing cataract surgery with implantation of RayOne Trifocal (Rayner IOL, Ltd.) intraocular lenses
AcrySof IQ PanOptix intraocular lenses
Eyes of patients undergoing cataract surgery with implantation of AcrySof IQ PanOptix (Alcon Laboratories, Inc.) intraocular lenses
Interventions
The Quality of Vision questionnaire rates glare, halos, starbursts, hazy/blurred/double vision, distortion, focusing difficulties, fluctuation, and depth perception conditions.
Eligibility Criteria
Patients underwent cataract surgery with trifocal intraocular lenses implantation in one or both eyes at Akdeniz University Hospital Ophtalmology Department.
You may qualify if:
- Patients underwent cataract surgery with trifocal intraocular lenses implantation in one or both eyes
You may not qualify if:
- Amblyopia
- Axial length (AL) over 25 mm
- Previous history of corneal or refractive surgery
- Ocular comorbidity (corneal scars, keratoconus, and corneal endothelial dystrophy, chronic or recurrent uveitis, macular degeneration, diabetes mellitus with retinal changes, glaucoma or intraocular pressure equal or higher than 24 mmHg)
- Patient inability to understand and/or fill in patient questionnaires
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aslı Çentinkaya Yaprak
Antalya, 070059, Turkey (Türkiye)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 30, 2020
First Posted
December 7, 2020
Study Start
November 30, 2020
Primary Completion
March 30, 2021
Study Completion
March 30, 2021
Last Updated
April 2, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share